Citation Impact
Citing Papers
Biomedically-relevant metal organic framework-hydrogel composites
2023 StandoutNobel
Sepsis-associated hyperlactatemia
2014
Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors
2016
A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS
2011
A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom
2017
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
2015 Standout
Polymeric hydrogels as a vitreous replacement strategy in the eye
2020
The Neovascular Age-Related Macular Degeneration Database
2014
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
2013 Standout
The molecular basis of human retinal and vitreoretinal diseases
2010 Standout
Targeting RNA splicing for disease therapy
2013
Ocular Drug Delivery
2010 Standout
Risk of Advanced Age-Related Macular Degeneration after Cataract Surgery in the Age-Related Eye Disease Study
2008
UK Age-Related Macular Degeneration Electronic Medical Record System (AMD EMR) Users Group Report IV
2016
Age-related macular degeneration
2012 Standout
Screening Examination of Premature Infants for Retinopathy of Prematurity
2018 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Current Status of Vascular Endothelial Growth Factor Inhibition in Age-Related Macular Degeneration
2010
Age-related macular degeneration
2018 Standout
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents
2016
Anti-Vascular Endothelial Growth Factors Protect Retinal Pigment Epithelium Cells Against Oxidation by Modulating Nitric Oxide Release and Autophagy
2017 Standout
Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies
2013
Risk factors and biomarkers of age-related macular degeneration
2016
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
N-Glycoproteome of E14.Tg2a Mouse Embryonic Stem Cells
2013
Ocular novel drug delivery: impacts of membranes and barriers
2008
Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies
2014
Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
2016
High molecular weight hyper-branched PCL-based thermogelling vitreous endotamponades
2021
Oligocone Trichromacy: Clinical and Molecular Genetic Investigations
2010
MOF–Thermogel Composites for Differentiated and Sustained Dual Drug Delivery
2023 StandoutNobel
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
Fish Consumption and Age-Related Macular Degeneration Incidence: A Meta-Analysis and Systematic Review of Prospective Cohort Studies
2016
Pathogenesis of central and complex sleep apnoea
2016
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
2016 Standout
Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity
2016
Genes and mutations causing retinitis pigmentosa
2013 Standout
Chemical Glycoproteomics
2016 StandoutNobel
Works of Daniel Barthelmes being referenced
Comparison of Outcomes from a Phase 3 Study of Age-Related Macular Degeneration with a Matched, Observational Cohort
2013
Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab
2008
Vascular endothelial growth factor plasma levels before and after treatment of neovascular age‐related macular degeneration with bevacizumab or ranibizumab
2011
Quantitative Analysis of OCT Characteristics in Patients with Achromatopsia and Blue-Cone Monochromatism
2006
U1 snRNA-mediated gene therapeutic correction of splice defects caused by an exceptionally mild BBS mutation
2011
Nocturnal Periodic Breathing during Acclimatization at Very High Altitude at Mount Muztagh Ata (7,546 m)
2010
Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study
2016
Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration
2015
Is Pseudophakia a Risk Factor for Neovascular Age-Related Macular Degeneration?
2007
Arterial Thromboembolic Events in Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Bevacizumab or Ranibizumab
2011
Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration
2016
Effect of site of lactate infusion on regional lactate exchange in pigs
2010
ThePROM1Mutation p.R373C Causes an Autosomal Dominant Bull's Eye Maculopathy Associated with Rod, Rod–Cone, and Macular Dystrophy
2010
INCREASED INTRAOCULAR PRESSURE IS A RISK FACTOR FOR UNEXPLAINED VISUAL LOSS DURING SILICONE OIL ENDOTAMPONADE
2017
First Clinical Experience with Anecortave Acetate (Retaane®)
2007
NovelTULP1Mutation Causing Leber Congenital Amaurosis or Early Onset Retinal Degeneration
2007
Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD
2011